1. Home
  2. HTD vs INMD Comparison

HTD vs INMD Comparison

Compare HTD & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

HTD

John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

HOLD

Current Price

$25.35

Market Cap

899.3M

Sector

Finance

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$13.82

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTD
INMD
Founded
N/A
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
899.3M
842.0M
IPO Year
2003
2018

Fundamental Metrics

Financial Performance
Metric
HTD
INMD
Price
$25.35
$13.82
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$17.33
AVG Volume (30 Days)
50.4K
768.1K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.74
Revenue Next Year
N/A
$3.26
P/E Ratio
N/A
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$22.40
$12.72
52 Week High
$26.21
$16.74

Technical Indicators

Market Signals
Indicator
HTD
INMD
Relative Strength Index (RSI) 52.43 44.92
Support Level $24.28 $13.27
Resistance Level $25.65 $13.87
Average True Range (ATR) 0.36 0.32
MACD -0.04 -0.03
Stochastic Oscillator 49.54 47.03

Price Performance

Historical Comparison
HTD
INMD

About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, convertible bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, communication services, materials, healthcare, real estate, consumer Staples, and short-term investments.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: